Skip to Content
Merck

Encephalopathy associated with bismuth subgallate therapy.

Clinical neuropharmacology (1993-04-01)
R P Friedland, A J Lerner, P Hedera, E P Brass
ABSTRACT

A 74-year-old man developed paranoid ideation, memory impairment, and defective gustatory and olfactory function while on bismuth subgallate therapy for use as a colostomy deodorant. Twenty-four-hour urine bismuth was elevated at 889 micrograms/day, and whole blood bismuth concentration was 67 micrograms/L. The patient improved after discontinuation of bismuth subgallate; there was resolution of paranoid behavior and gustatory and olfactory functions improved. Follow-up whole blood bismuth concentration was 21 micrograms/L 4 weeks after cessation. Altered gustatory and olfactory function have not been previously reported with bismuth intoxication.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Bismuth(III) gallate basic hydrate, ≥98.0% (calc. on dry substance, KT)